Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory diseaseAlfredo Berruti, Luigi Dogliotti, Lucianna Russo et al.|Endocrine Related Cancer|2005Cited by 136
Chromogranin A Expression in Patients With Hormone Naïve Prostate Cancer Predicts the Development of Hormone Refractory DiseaseAlfredo Berruti, Luigi Dogliotti, Alessandra Mosca et al.|The Journal of Urology|2007Cited by 89
Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic FactorsMatteo Santoni, Nicola Battelli, Daniel Y.C. Heng et al.|Cancers|2019Cited by 31